Skip to content
healthcare.dev

Liothyronine sodium

NDC 70377-115, Liothyronine sodium, tablet, from Biocon Pharma Inc..

Product NDC
70377-115
Status
Listed
Labeler
Biocon Pharma Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218070
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70377-115 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM25 ug/1

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
70377-115-117037701151190 TABLET in 1 BOTTLE (70377-115-11)
70377-115-1270377011512100 TABLET in 1 BOTTLE (70377-115-12)
70377-115-13703770115131000 TABLET in 1 BOTTLE (70377-115-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/21002702-422b-1402-73b8-670314d8e579
  • NADAC price for package 70377011512

    GET /v1/drugs/nadac/70377011512

Use it

Look up 70377-115 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70377-115 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70377-115. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.